© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to August
oral, brain-penetrant, reversible MAGL inh.
in vivo PK/PD in CNS (0.3-10 mpk PO)
from HTS and SBDD
Journal of Medicinal Chemistry
Takeda, Fujisawa, Japan
The Takeda MAGL inhibitor, “compound 4f”, was selected by reviewer Joachim Rudolph. “MAGL (monoacylglycerol lipase) is implicated in neuroinflammation, and inhibitors of this enzyme are of interest as therapeutics in neurodegenerative…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.